|
1
|
Picci P: Osteosarcoma (osteogenic
sarcoma). Orphanet J Rare Dis. 2:62007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferrari S and Palmerini E: Adjuvant and
neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr
Opin Oncol. 19:341–346. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chung LC, Tsui KH, Feng TH, Lee SL, Chang
PL and Juang HH: L-Mimosine blocks cell proliferation via
upregulation of B-cell translocation gene 2 and N-myc downstream
regulated gene 1 in prostate carcinoma cells. Am J Physiol Cell
Physiol. 302:C676–C685. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zalatnai A and Bocsi J: Mimosine, a
plant-derived amino acid induces apoptosis in human pancreatic
cancer xenografts. Anticancer Res. 23:4007–4009. 2003.PubMed/NCBI
|
|
6
|
Kulp KS and Vulliet PR: Mimosine blocks
cell cycle progression by chelating iron in asynchronous human
breast cancer cells. Toxicol Appl Pharmacol. 139:356–364. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hughes TA and Cook PR: Mimosine arrests
the cell cycle after cells enter S-phase. Exp Cell Res.
222:275–280. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hwang HS, Davis TW, Houghton JA and
Kinsella TJ: Radiosensitivity of thymidylate synthase-deficient
human tumor cells is affected by progression through the G1
restriction point into S-phase: Implications for fluoropyrimidine
radiosensitization. Cancer Res. 60:92–100. 2000.PubMed/NCBI
|
|
9
|
Lalande M: A reversible arrest point in
the late G1 phase of the mammalian cell cycle. Exp Cell Res.
186:332–339. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mosca PJ, Dijkwel PA and Hamlin JL: The
plant amino acid mimosine may inhibit initiation at origins of
replication in Chinese hamster cells. Mol Cell Biol. 12:4375–4383.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gilbert DM, Neilson A, Miyazawa H,
DePamphilis ML and Burhans WC: Mimosine arrests DNA synthesis at
replication forks by inhibiting deoxyribonucleotide metabolism. J
Biol Chem. 270:9597–9606. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kalejta RF and Hamlin JL: The dual effect
of mimosine on DNA replication. Exp Cell Res. 231:173–183. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krude T: Mimosine arrests proliferating
human cells before onset of DNA replication in a dose-dependent
manner. Exp Cell Res. 247:148–159. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang HC, Lee TH, Chuang LY, Yen MH and
Hung WC: Inhibitory effect of mimosine on proliferation of human
lung cancer cells is mediated by multiple mechanisms. Cancer Lett.
145:1–8. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oppenheim EW, Nasrallah IM, Mastri MG and
Stover PJ: Mimosine is a cell-specific antagonist of folate
metabolism. J Biol Chem. 275:19268–19274. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang HC, Weng CF, Yen MH, Chuang LY and
Hung WC: Modulation of cell cycle regulatory protein expression and
suppression of tumor growth by mimosine in nude mice. Int J Oncol.
17:659–665. 2000.PubMed/NCBI
|
|
17
|
Dong Z and Zhang JT: EIF3 p170, a mediator
of mimosine effect on protein synthesis and cell cycle progression.
Mol Biol Cell. 14:3942–3951. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen J, Yin JY, Li XP, Liu ZQ, Wang Y,
Chen J, Qu J, Xu XJ, McLeod HL, He YJ, et al: The prognostic value
of altered eIF3a and its association with p27 in non-small cell
lung cancers. PLoS One. 9:e960082014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Staunton MJ and Gaffney EF: Tumor type is
a determinant of susceptibility to apoptosis. Am J Clin Pathol.
103:300–307. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fisher DE: Apoptosis in cancer therapy:
Crossing the threshold. Cell. 78:539–542. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fan S, Smith ML, Rivet DJ II, Duba D, Zhan
Q, Kohn KW, Fornace AJ Jr and O'Connor PM: Disruption of p53
function sensitizes breast cancer MCF-7 cells to cisplatin and
pentoxifylline. Cancer Res. 55:1649–1654. 1995.PubMed/NCBI
|
|
22
|
Le NT and Richardson DR: Iron chelators
with high antiproliferative activity up-regulate the expression of
a growth inhibitory and metastasis suppressor gene: A link between
iron metabolism and proliferation. Blood. 104:2967–2975. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zalatnai A: P-glycoprotein expression is
induced in human pancreatic cancer xenografts during treatment with
a cell cycle regulator, mimosine. Pathol Oncol Res. 11:164–169.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lavrik IN, Golks A and Krammer PH:
Caspases: Pharmacological manipulation of cell death. J Clin
Invest. 115:2665–2672. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grütter MG: Caspases: Key players in
programmed cell death. Curr Opin Struct Biol. 10:649–655. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hata AN, Engelman JA and Faber AC: The
BCL2 family: Key mediators of the apoptotic response to targeted
anticancer therapeutics. Cancer Discov. 5:475–487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei MC, Zong WX, Cheng EH, Lindsten T,
Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and
Korsmeyer SJ: Proapoptotic BAX and BAK: A requisite gateway to
mitochondrial dysfunction and death. Science. 292:727–730. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Parsons MJ and Green DR: Mitochondria in
cell death. Essays Biochem. 47:99–114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kantari C and Walczak H: Caspase-8 and
bid: Caught in the act between death receptors and mitochondria.
Biochim Biophys Acta. 1813:558–563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim B, Srivastava SK and Kim SH: Caspase-9
as a therapeutic target for treating cancer. Expert Opin Ther
Targets. 19:113–127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gu X and Manautou JE: Molecular mechanisms
underlying chemical liver injury. Expert Rev Mol Med. 14:e42012.
View Article : Google Scholar : PubMed/NCBI
|
